Dabrafenib and Trametinib in Treating Patients With Erdheim Chester Disease With BRAF V600 Mutations
Clinical trial NCT03794297 · WITHDRAWN
Trial details
- NCT number
- NCT03794297
- Sponsor
- National Cancer Institute (NCI)
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-04
- Primary completion
- 2021-02-18
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.